ADVERTISEMENT

Onderstepoort Biological Products (OBP)

Financial Information

All Financial Values: R'0002024/252023/242022/232021/222020/21
 
AUDIT OUTCOME QualifiedQualifiedQualifiedFinancially UnqualifiedFinancially Unqualified
 
FINANCIAL POSITION
Current Assets418 511531 717478 241426 615425 479
Non-Current Assets441 460411 196388 615343 344351 727
Total Assets859 971942 913866 856769 959777 206
Current Liabilities61 852112 80391 69334 25834 505
Non-Current Liabilities436 740452 886454 565456 420468 777
Total Liabilities498 592565 689546 259490 678503 282
Total Net Assets361 379377 224320 596279 281273 924
 
FINANCIAL PERFORMANCE
Total Revenue225 851282 246258 836208 667253 692
Revenue from Exchange Transactionsn/an/an/an/an/a
Revenue from Non-Exchange Transactionsn/an/an/an/an/a
Total Expenditure(241 680)(244 963)(227 167)(203 310)(252 239)
Employee Related costs(75 096)(67 594)(87 191)(92 501)(92 426)
Surplus/(Deficit) for Year(15 829)37 28331 6695 3571 453
 
CASH FLOW
Net Cash Flows from Operating Activities(64 554)94 952109 13141 0196 693
Net Cash Flows from Investing Activities(49 683)(12 570)(44 393)(6 358)(18 469)
Cash & Cash Equivalents at End of Year339 231458 531373 371308 778274 289
 
UIFW EXPENDITURE
Unauthorised Expenditure-----
Irregular Expenditure4373 153-4249 400
Fruitless & Wasteful Expenditure--8-4 948
 
HUMAN RESOURCES
Posts Approvedn/a265278278277
Posts Filled186174196196205
 
SOURCEAnnual ReportAnnual ReportAnnual ReportAnnual ReportAnnual Report

The information in this directory is compiled from various sources and is subject to continual change. If you notice any errors or omissions, contact us so that we may correct them.

ADVERTISEMENT
ADVERTISEMENT